Monday, March 25, 2019

Equity Corporate Actions Alert #2019 - 56
Information Regarding the Business Combination of Bioblast Pharma Ltd. (ORPN) and Enlivex Therapeutics Ltd.

Category:

  • Industry Announcement

Markets Impacted:

Contact Information:

Resources


The business combination of Bioblast Pharma Ltd. (ORPN) and Envilex Therapeutics Ltd. is expected to become effective on Tuesday, March 26, 2019, subject to the closing of the private placement transaction. Upon effectiveness, the common stock of Bioblast Pharma Ltd. will undergo a change of name, symbol, and CUSIP number. Further, Bioblast Pharma Ltd. has declared a distribution of one (1) non-transferable Contingent Value Right (CVR) to payable on March 25, 2019, payable on the same date. The common stock will not be declared EX for this distribution.

The details of the name, symbol and CUSIP changes are follows:

Current Company Name: Bioblast Pharma Ltd.
New Company Name: Enlivex Therapeutics Ltd.
Issue: Ordinary Shares
Current CUSIP: M20156127
New CUSIP: M4130Y106
Current Symbol: ORPN
New Symbol: ENLV
Marketplace Effective Date: Tuesday, March 26, 2019

If you would like to register as a market maker in ENLV, contact Nasdaq Trading Services at +1 212 231 5100.



Email Alert Subscriptions:
Nasdaq offers customers the ability to self select news delivery across various Nasdaq markets. Create and maintain a profile for updating alert preferences and contact information. Visit the enrollment form on the Nasdaq Trader website and sign up today! Please note that if you choose to unsubscribe from an email list, you may no longer receive potentially critical emails from the NASDAQ Stock Market regarding Nasdaq's trading and data products, regulatory issues or marketplace initiatives. To unsubscribe, also click on the enrollment form

Please follow Nasdaq on Facebook RSS and Twitter.

Nasdaq (Nasdaq: NDAQ) is a leading global provider of trading, clearing, exchange technology, listing, information and public company services. Through its diverse portfolio of solutions, Nasdaq enables customers to plan, optimize and execute their business vision with confidence, using proven technologies that provide transparency and insight for navigating today's global capital markets. As the creator of the world's first electronic stock market, its technology powers more than 90 marketplaces in 50 countries, and 1 in 10 of the world's securities transactions. Nasdaq is home to approximately 3,900 total listings with a market value of approximately $13 trillion. To learn more, visit: business.nasdaq.com.